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Abstract. 
 
Using the yeast two-hybrid system and an in 
vitro binding assay, we have identified a novel protein 
termed vinexin as a vinculin-binding protein. By North-
ern blotting, we identified two types of vinexin mRNA 
that were 3 and 2 kb in length. Screening for full-length 
cDNA clones and sequencing indicated that the two 
mRNA encode 82- and 37-kD polypeptides termed vin-
exin 
 
a
 
 and 
 
b
 
, respectively. Both forms of vinexin share 
a common carboxyl-terminal sequence containing three 
SH3 domains. The larger vinexin 
 
a
 
 contains an addi-
tional amino-terminal sequence. The interaction be-
tween vinexin and vinculin was mediated by two SH3 
domains of vinexin and the proline-rich region of vincu-
lin. When expressed, vinexin 
 
a
 
 and 
 
b
 
 localized to focal 
adhesions in NIH 3T3 fibroblasts, and to cellÐcell junc-
tions in epithelial LLC-PK1 cells. Furthermore, expres-
sion of vinexin increased focal adhesion size. Vinexin 
 
a
 
 
also promoted upregulation of actin stress fiber forma-
tion. In addition, cell lines stably expressing vinexin 
 
b
 
 
showed enhanced cell spreading on fibronectin. These 
data identify vinexin as a novel focal adhesion and cellÐ
cell adhesion protein that binds via SH3 domains to the 
hinge region of vinculin, which can enhance actin cy-
toskeletal organization and cell spreading.
Key words: actin cytoskeleton ¥ cell adhesion ¥ focal 
adhesion ¥ SH3 domain ¥ vinculin
 
V
 
INCULIN
 
 is an abundant cytoskeletal protein found
in integrin-mediated cell-substrate adhesion sites
(focal adhesions) and also in cadherin-mediated
cellÐcell adhesions (adherens junctions). Vinculin binds in
vitro to cytoskeletal proteins such as talin, paxillin, 
 
a
 
-actinin,
and F-actin. By complex formation with these cytoskeletal
proteins, vinculin is thought to contribute to organization
of the actin cytoskeleton induced by integrin-meditated
cell adhesion (Jockusch et al., 1995; Yamada and Geiger,
1997). Indeed, elevation or knock out of vinculin expres-
sion results in substantial alteration of cell adhesivity and
motility (Rodrguez Fernndez et al., 1993; Varnum-Finney
and Reichardt, 1994; Coll et al., 1995; Goldmann et al.,
1995; Volberg et al., 1995).
From studies with proteolytic fragments of vinculin and
electron microscopy, vinculin appears to be composed of a
large globular ÒheadÓ domain and a rod-like ÒtailÓ domain
(Milam, 1985; Molony and Burridge, 1985). The head do-
main binds to 
 
a
 
-actinin and to talin, whereas the tail do-
main binds to F-actin and to the vinculin tail domain itself
in an intermolecular interaction (for a review, see Jock-
usch et al., 1995). In the hinge region between the head
and tail domains, vinculin has a short proline-rich se-
quence.
To date, many cytoskeletal proteins have been identi-
fied in focal adhesion and adherens junctions. Although
numerous studies have elucidated the functions of these
proteins and their interactions, little is known about the
regulation of the topology of these interactions. Interest-
ingly, the intramolecular interaction between the head
and tail domain of vinculin has been suggested to modu-
late its interaction with the other cytoskeletal proteins,
talin (Johnson and Craig, 1994), 
 
a
 
-actinin (Kroemker et
al., 1994), and F-actin (Johnson and Craig, 1995), as well
as serine/threonine phosphorylation (Schwienbacher et
al., 1996). Furthermore, phosphatidylinositol-4,5-bisphos-
phate (PIP2)
 
 
 
has been found to dissociate vinculinÕs headÐ
tail interaction, unmasking its talin- and actin-binding sites
(Gilmore and Burridge, 1996; Weekes et al., 1996). There-
fore, alteration of the conformation of vinculin is a poten-
tial regulatory mechanism for actin cytoskeletal changes.
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Because of the potentially important location of the pro-
line-rich region of vinculin and a high degree of sequence
conservation of this region from 
 
Caenorhabditis elegans
 
 to
human, we screened for binding proteins to this region us-
ing the yeast two-hybrid system. Here we report the iden-
tification and characterization of a novel vinculin-binding
protein designated as vinexin. 
 
Materials and Methods
 
Screening for a Vinculin-binding Protein
 
Two bait plasmids used for two-hybrid screening (Fields and Song, 1989;
Chien et al., 1991), pGB410 and pGB411, contained the proline-rich re-
gion of chicken vinculin (see Fig. 1) fused with the GAL4 DNA-binding
domain of pGBT9 (Clontech). The proline-rich region was amplified by
PCR with primer pairs 409 (5
 
9
 
GCCGAATTCCAGCCTCAGGAGCC-
AGACTTTC3
 
9
 
) and 410 (5
 
9
 
GAAGTCGACTAATTGCTAGCTTCTC-
CTGCTTTC3
 
9
 
), 409 and 411 (5
 
9
 
CCCGTCGACTACTTGCTAGACC-
ATTTCCGAGC3
 
9
 
), using a chicken vinculin cDNA clone as the template
(kindly provided by Dr. Benjamin Geiger, The Weizmann Institute, Re-
hovot, Israel). The resulting PCR fragments were cut with EcoRI and
SalI, and cloned into pGBT9.
The yeast strain HF7c (MATa, ura3-52, his3-200, ade2-101, lys2-801,
trp-1-901, leu2-3, 112, gal4-542, gal80-538, LYS2::GAL1
 
UAS
 
-GAL1
 
TATA
 
-
HIS3, URA3::GAL4
 
17mers(x3)
 
-CYC1
 
TATA
 
-lacZ) was transformed first with
the bait plasmid, pGB410, and subsequently with a human placenta
cDNA library (Clontech) fused to the GAL4 transcription-activating do-
main. Histidine autotrophic colonies were selected after incubation for 7 d
on media plates lacking histidine, lysed in liquid nitrogen, and then as-
sayed for 
 
b
 
 galactosidase activity on filters. The prey plasmids were recov-
ered from the positive colonies and reintroduced into HF7c with pGB410,
pGB411, or a control plasmid pLAM5
 
9
 
, which carries a human lamin C/
GAL4 DNA binding domain hybrid in pGBT9 to exclude false positives.
To isolate full-length vinexin cDNA, a human HeLa 5
 
9
 
-stretch plus
cDNA library (Clontech) and a mouse 13.5-d embryo cDNA library
(kindly provided by Dr. Yoshihiko Yamada, National Institutes of Health
[NIH], Bethesda, MD) were screened by plaque hybridization using the
insert of the positive clone as a probe. The probe was labeled with 
 
32
 
P us-
ing a randomly primed DNA labeling kit (Boehringer Mannheim).
 
Mapping of the Vinculin Binding Site
 
To map the vinculin binding site in the vinexin sequence, the yeast two-
hybrid system was used to detect interactions between deletion mutants of
vinexin and vinculin proline-rich regions. Primer pairs N1 (5
 
9
 
AATG-
AATTCGCCGCCAGGCTCAAGTTT3
 
9
 
) and C1 (5
 
9
 
AATGTCGACG-
GGCAGCACCTCCACATA3
 
9
 
), N2 (5
 
9
 
GAAGAATTCGAGGTTGTG-
GCCCAGT3
 
9
 
), and C2 (5
 
9
 
TATGTCGACTTCACGAGACACCTGC3
 
9
 
),
and N1 and C2 were used for PCR to construct the plasmids
pGAD1stSH3, pGAD2ndSH3, and pGAD1st2ndSH3, respectively. The
resulting PCR products were digested with EcoRI and SalI and ligated
into pGAD424 and sequenced. PCR was also used to amplify the deleted
vinculin proline-rich region, pGB410d1 and pGB410d2, with primer pairs
729A (5
 
9
 
GCCGAATTCCATCTCCATCTGACTGATG3
 
9
 
) and 410, and
729B (5
 
9
 
AGAGAATTCCCAGAAGGTGAGGTTCCC3
 
9
 
) and 410, re-
spectively. The PCR products were digested with EcoRI and SalI and sub-
cloned into pGBT9.
After cotransformation of HF7c with the vinculin proline-rich region in
pGBT9 and the vinexin deletion mutants in pGAD424, transformants
were assayed for 
 
b
 
 galactosidase activity on filters or in solution.
 
In Vitro Binding Assay Using Affinity Precipitation
 
For an in vitro binding assay, various glutathione S-transferase (GST)
 
1
 
 fu-
sion proteins were expressed in 
 
Escherichia coli
 
 using the inserts of
pGAD424 plasmids described above and GST expression plasmid pGEX-
4T-1 (Pharmacia Fine Chemicals). To construct a GST fusion protein con-
taining the first SH3 domain and a linker region between the two SH3 do-
mains (clone pGAD1stSH3L), primer pairs N1 and CL (5
 
9
 
AATG-
TCGACTCCATACTCCAGCACCTG3
 
9
 
) were used for PCR, and the
product was subcloned into pGEX-4T-1. GST fusion proteins were ex-
pressed in 
 
E
 
.
 
 coli
 
 and purified with glutathione Sepharose 4B (Pharmacia
Fine Chemicals) according to the supplierÕs instructions. Cultured human
foreskin fibroblasts (kindly provided by Susan Yamada, NIH) were
washed twice with PBS and lysed in NP-40 lysis buffer (0.5% NP-40, 100
 
m
 
g/ml PMSF, 10 
 
m
 
g/ml aprotinin, 0.1 mM sodium orthovanadate). The ly-
sate containing 400 
 
m
 
g total protein as estimated by microBCA assay
(Pierce Chemical Co.) was incubated with 5 
 
m
 
g each of GST fusion pro-
tein and glutathione-Sepharose 4B at 4
 
8
 
C for 16 h. After four washes with
lysis buffer, proteins were extracted from the Sepharose beads by boiling
in loading buffer, resolved by 8% SDS-PAGE, and transferred to an Im-
mobilon-P membrane (Millipore Corp.). Coprecipitated vinculin was de-
tected by Western blotting using antiÐhuman vinculin monoclonal anti-
body VII-F9 (a kind gift of Dr. Victor Koteliansky, Biogen, Inc.,
Cambridge, MA).
 
Northern Blotting
 
The cDNA of vinexin was labeled as described above and used to probe
the human multiple tissue Northern blot (Clontech) containing 2 
 
m
 
g of
polyA
 
1
 
 RNA.
 
Production of Polyclonal Antibody
 
Rabbit antiserum was raised against a recombinant vinexin fragment ex-
pressed by histidine-tagged bacterial expression vector pET22a (Novagen,
Madison, WI) containing the vinexin cDNA insert of the clone (pVBP)
isolated by the yeast two-hybrid screening. Polyclonal antibodies were af-
finity-purified using the recombinant protein covalently conjugated to Af-
figel 10 (Bio-Rad Laboratories). The bound antibodies were subsequently
passed through an Affigel 10 column conjugated with 
 
E
 
.
 
 coli
 
 whole pro-
tein extract to remove nonspecific antibodies.
 
Cell Lines
 
NIH 3T3, HeLa, C2C12, and LLC-PK1 cells were originally obtained
from American Type Culture Collection and maintained in our labora-
tory. Mouse myoblastic C2C12 cells (Yaffe and Saxel, 1977) were induced
to differentiate to myotubes by culturing with 10% horse serum for 6 d.
Porcine kidney epithelial LLC-PK1 cells (Tanigawara et al., 1992) form a
highly polarized monolayer, and were used to test vinexin localization in
an epithelial cell.
 
Western Blotting
 
Cells were extracted with lysis buffer (1.0% Triton X-100, 1.0% sodium
deoxycholate, 0.1% SDS) containing 100 
 
m
 
g/ml PMSF, 10 
 
m
 
g/ml aproti-
nin, 10 
 
m
 
g/ml leupeptin, and 2.5 mM EGTA. Extracted proteins (80 
 
m
 
g)
were boiled in loading buffer for 3 min, resolved by 8% SDS-PAGE, and
transferred to an Immobilon-P membrane. The filter was blocked with
Block Ace (Dainippon Pharmaceutical), incubated with 0.66 
 
m
 
g/ml affin-
ity-purified antiÐvinexin antibody for 1 h, rinsed in TBS (100 mM Tris, pH
7.5, 150 mM NaCl) containing 0.1% Tween 20. Immune complexes were
visualized with goat antiÐrabbit IgG horseradish peroxidaseÐconjugated
secondary antibody (Bio-Rad Laboratories) and developed using the
ECL kit (Amersham International).
 
Subcellular Localization of Vinexin
 
Mouse vinexin 
 
a
 
 and 
 
b
 
 were tagged with Green Fluorescent Protein
(GFP) or FLAG epitope (Eastman Kodak Co.) at the amino termini using
the expression plasmids pGZ21 or p401F, respectively. pGZ21 contains a
cytomegalovirus promoter and a GFP coding sequence with three amino
acid residue substitutions (S65A, V68L, and S72A) to increase its fluores-
cence in mammalian cells (Cormack et al., 1996). Plasmid p401F is similar
to pGZ21, but contains the FLAG epitope instead of GFP, and a neomy-
cin-resistance gene for G418 selection. To construct the expression plas-
mid for the GFP-tagged amino-terminal half of vinexin 
 
a 
 
(pGFPVxH), an
internal AccI restriction site was used to delete the carboxy-terminal half
of vinexin 
 
a
 
. PCR was used to amplify the DNA fragment for the third
SH3 domain to construct pGFP3rdSH3.
NIH 3T3 cells were plated on coverslips 24 h after transfection of the
expression plasmids using LipofectAMINE (Life Technologies, Inc.). We
routinely observed that 
 
z
 
10Ð40% of the treated cells expressed vinexin or
 
1. 
 
Abbreviations used in this paper:
 
 GFP, green fluorescent protein; GST,
glutathione S-transferase; VASP, vasodilator-stimulated phosphoprotein. 
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its fragments directed by each respective expression plasmid. After 24 h
further incubation, the cells were fixed in 4% paraformaldehyde and 5%
sucrose in PBS
 
1
 
 (PBS with 0.87 mM CaCl
 
2
 
, 0.49 mM MgCl
 
2
 
) for 30 min,
and permeabilized for 5 min in 0.4% Triton X-100 in PBS
 
1
 
. The cells
were blocked with 10% goat serum in PBS
 
1
 
 for 1 h, followed by incuba-
tion with antivinculin antibody. The cells were then stained with Texas
RedÐlabeled sheep antiÐmouse IgG anti-body (Amersham International)
for 1 h. For F-actin staining, rhodamine-phalloidin (Molecular Probes,
Inc.) was used. The fluorescence images were photographed by an Axio-
vert fluorescent microscope equipped with epifluorescence (Carl Zeiss
Jena). For observing GFP fluorescence, a filter set for FITC supplied by
Carl Zeiss Jena was used. The confocal microscope images were obtained
using a Fluoview Confocal Laser Scanning microscope (Olympus Corp.).
 
Cell-spreading Assay
 
FLAG-tagged vinexin expression plasmids were constructed using the
vector p401F described above. Geneticin at 800 
 
m
 
g/ml (Life Technologies,
Inc.) was added to C2C12 cells 48 h after transfection with expression
plasmids for FLAG-tagged vinexin 
 
a
 
, vinexin 
 
b
 
, or p401F alone. Geneti-
cin-resistant clones expressing vinexin were selected and assayed by West-
ern blotting. In a cell-spreading assay (Aota et al., 1994), cells were al-
lowed to adhere and spread for 1 h on human plasma fibronectin coated at
1 
 
m
 
g/ml. 
 
Results
 
Cloning and the Tissue Distribution of Vinexin
 
We used the proline-rich region of chicken vinculin for
bait plasmids in the yeast two-hybrid method (Fig. 1), and
screened a cDNA library constructed from human pla-
centa polyA
 
1
 
 RNA. Four positive clones were isolated
from 2 
 
3 
 
10
 
6
 
 transformants. All four clones had an identi-
cal 1 kb cDNA fragment, and were designated pVBP. The
insert of the clone contained two SH3 domains. We used
the insert of pVBP as a probe for further screening to iso-
late full length cDNA clones, and for Northern blotting.
As shown in Fig. 2, we detected two types of mRNA
molecules by Northern blotting that were 3 and 2 kb in
length. The two mRNA species showed varying levels of
expression in different human tissues. The 2-kb mRNA
molecule was generally expressed at higher levels than the
3-kb molecule, and an especially high expression level was
detected in heart for the 2-kb molecule. In contrast, a high
expression level of the 3-kb molecule was observed in
skeletal muscle. Interestingly, vinculin expression levels
roughly correlated with the combined expression levels of
the two types of vinexin mRNA molecule (Fig. 2).
When cDNA library screening was performed with
pVBP as the probe, we were able to isolate only the 2-kb
type of cDNA from HeLa cells. This result was consistent
with the results of Northern blotting, where the 3-kb type
of vinexin was not detected in HeLa cells (data not
shown). We isolated 3-kbÐtype cDNA clones from a
mouse embryo cDNA library. A schematic representation
of these clones is shown in Fig. 3 A. The longer clone,
p3A9, encodes an open reading frame of 82 kD, whereas
the protein size predicted from the 2-kbÐtype cDNA
clones is 37 kD. We designated these two proteins vinexin
 
a
 
 and 
 
b
 
, respectively. Vinexin 
 
b
 
 corresponds to the car-
Figure 1. Construction of bait plasmids. The se-
quences from the vinculin prolineÐrich region
used for bait plasmids are indicated by the black
bars along with an alignment of vinculin se-
quences from C. elegans, human, and chicken.
The asterisks indicate the amino acid residues
conserved among these species. The numbers in-
dicate the positions of the corresponding amino
acid residues from each amino-terminal end.
Figure 2. Northern blotting using vinexin cDNA. The insert of
plasmid pVBP was labeled with 32P and hybridized with polyA1
RNA resolved by electrophoresis and transferred to a Nylon
membrane. Autoradiography of the blot is shown with the mobil-
ities and sizes of molecular weight markers. The tissue sources of
the polyA1 RNA are indicated along the top. Northern blotting
patterns of vinculin and actin are also shown. 
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boxyl-terminal half of vinexin 
 
a
 
 (Fig. 3 B). Since the 5
 
9 
 
end
of the untranslated region of the cDNA clones from HeLa
cells has a unique sequence not found so far in vinexin 
 
a
 
cDNA clones, it is likely that two distinct alternative pro-
moters give rise to the two different mRNA molecules.
To confirm that vinexin was actually expressed as ex-
pected, cultured cell lines were extracted with RIPA
buffer, and Western blotting was performed with antivi-
nexin polyclonal antibody. In NIH 3T3, HeLa, and LLC-
PK1 cells, a protein band with an estimated mol wt of 38 kD
was detected, suggesting that vinexin 
 
b
 
 is the major form
in these cells (Fig. 4). In mouse myoblastic C2C12 cells,
both vinexin 
 
a
 
 and 
 
b
 
 were detected. Interestingly, down-
regulation of vinexin 
 
b
 
 was detected after induction of
C2C12 differentiation. In HeLa and differentiated C2C12
cells, additional bands of 
 
z
 
30 and 75 kD were detected,
indicating that there may be additional subtypes of vi-
nexin, or, less likely, protein degradation.
 
Mapping of Vinculin Binding Site of Vinexin
 
Vinexin 
 
a
 
 and 
 
b
 
 share a common carboxyl-terminal se-
quence that contains the three SH3 domains. Clone pVBP
isolated by the yeast two-hybrid screening contains the
first and second SH3 domains (Fig. 3). To map the region
for vinculin binding, various segments of vinexin were
fused with the GAL4 activation domain in the plasmid
pGAD424 (Fig. 5 A). They were introduced into the yeast
strain HF7c with plasmid pGB410, which contains the pro-
line-rich region of vinculin fused with the GAL4 DNA-
binding domain. The results of 
 
b
 
 galactosidase activity as-
says for each clone are shown in Fig. 5 B. Vinculin binding
Figure 3. Schematic diagram of domain organi-
zation of vinexin and its predicted amino acid se-
quence. (A) The open reading frame of vinexin is
shown by open boxes. The grey boxes within the
open reading frame indicate the three SH3 do-
mains, and they are numbered sequentially from
the amino terminus. The approximate position of
each cDNA clone is shown by a line with its
name under the corresponding schematic repre-
sentation of each type of mRNA molecule. The
59 end sequence unique to vinexin b is shaded
with diagonal stripes, and is located at the 59 un-
translated region of vinexin b. (B) The 733
amino acid open reading frame contains three
SH3 domains, indicated by boxes. The predicted
amino-terminal end of vinexin b is shown by the
arrow. A sequence motif search identified the
three SH3 domains and a potential nuclear local-
ization signal (underlined), although the impor-
tance of the latter is not clear at present. The nu-
cleotide sequence data are available from
Genbank/EMBL/DDBJ under accession Nos.
AF064806 and AF064807.
Figure 4. Western blotting pat-
tern of vinexin. Protein samples
extracted from LLC-PK1, HeLa,
NIH 3T3, undifferentiated C2C12,
and differentiated C2C12 cells
were resolved by SDS-PAGE.
This figure shows their Western
blotting patterns using affinity-
purified polyclonal antibody
prepared against a recombinant
vinexin fragment. Note that at
least in HeLa and differentiated
C2C12 cells there are additional
bands other than vinexin a and
b (see text). 
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was not detected with either the first or second SH3 do-
main alone, whereas the clone with the first two SH3 do-
mains showed vinculin binding.
The results of the two-hybrid assays were consistent
with the results from an in vitro binding assay using GST
fusion proteins. In this experiment, various parts of vi-
nexin were expressed in E. coli as GST fusion proteins and
were then bound to glutathione beads. The beads were in-
cubated with cell lysate, washed, and then eluted fractions
were analyzed by Western blotting using antivinculin anti-
body. As shown in Fig. 6, the first or the second SH3 do-
main alone, or the first SH3 domain with linker region
(1stSH3L, Fig. 5 A) could not bind vinculin, whereas the
clone containing the two SH3 domains bound vinculin in
vitro. Thus, the minimal vinculin binding site was mapped
to a region extending from the first to the second SH3 do-
main of vinexin. The binding activity of this minimal re-
gion was less than that of pVBP. One possible explanation
is that the 59 end region of pVBP may have an additional
activity (discussed later), and another is that the GAL4
DNA-binding domain or GST is fused too close to the first
SH3 domain in these clones.
Mapping of Vinexin-binding Site
To map the vinexin-binding site within the proline-rich re-
gion of vinculin more precisely, new bait plasmids with
various parts of the proline-rich region were constructed
(Fig. 7 A). The amino acid sequence from the 849th to
893rd amino acid residues of chicken vinculin (pGB410d1)
showed vinexin binding in this experiment, but residues
866Ð893 (pGB410d2) did not (Fig. 7 B). Thus, the vinexin-
binding site is within residues 849Ð893. This vinexin-bind-
ing region is especially well conserved from C. elegans to
human (48% identity, Fig. 1).
Expression of Vinexin
To determine the subcellular localization of vinexin, GFP-
tagged vinexin a and b (Fig. 8) were transfected into NIH
3T3 cells. The subcellular localization of vinexin was ob-
served by GFP fluorescence, and the same cells were also
Figure 5. VinculinÐvinexin interaction assayed by b galactosi-
dase activity in the yeast two-hybrid system. (A) A schematic dia-
gram of deletion constructs is presented. The DNA fragments
containing the first and/or second SH3 domain were amplified by
PCR using appropriate primers, cloned in plasmid pGAD424 or
pGST4T-1, and sequenced. The numbered gray boxes indicate
the first and second SH3 domains of vinexin, respectively. (B)
The activities of b galactosidase (in arbitrary units) in the lysate
of each combination of bait and prey plasmids are shown. (410)
pGB410, which contains the proline-rich region of vinculin in
plasmid pGBT9, used for the bait plasmid. (CskSH3) pGAD424-
based plasmid with the SH3 domain of Csk, included as a control.
The experiment was repeated three times independently, and the
averages and SD are shown.
Figure 6. In vitro binding assay of vinculinÐvinexin interaction.
Protein extract from cultured human foreskin fibroblasts was in-
cubated with GST fusion proteins with various parts of vinexin
(Fig. 5) and glutathione-Sepharose beads as described in Materi-
als and Methods. After extensive washing, proteins extracted
from the beads were analyzed by Western blotting using antivin-
culin monoclonal antibody VII-F9. The GST fusion proteins cor-
responding to each lane are indicated along the top. See Fig. 5 A
for a schematic diagram of these plasmids.The Journal of Cell Biology, Volume 144, 1999 64
stained with antivinculin monoclonal antibody VII-F9 and
a Texas RedÐlabeled second antibody (Fig. 9). Both GFP-
fused vinexin isoforms were predominantly localized at fo-
cal adhesions, and both colocalized with endogenous vin-
culin, although vinexin b was also found in the cytoplasm
and sometimes in the nucleus. In NIH 3T3 cells highly ex-
pressing GFP-vinexin a, we sometimes observed vinculin-
free dot-like GFP fluorescence, which is apparently ag-
gregation of overexpressed GFP-vinexin a fusion protein
(Fig. 9, A and B). FLAG-tagged vinexin a and vinexin b
also localized to focal adhesions, and nontagged vinexin
(expressed using clone p3A9) was also detected at focal
adhesions by indirect immunostaining with antivinexin
polyclonal antibody (data not shown). Thus, vinexin is a
novel focal adhesion protein, and it colocalizes with vincu-
lin. Interestingly, increased vinculin staining in focal adhe-
sions was observed in the cells expressing vinexin a (Fig. 9,
A and B). This finding may indicate the ability of vinexin
a to recruit vinculin from the diffuse pool to focal adhe-
sions, or to stabilize vinculin in focal adhesions.
Since vinculin can be found in cellÐcell adhesions, vi-
nexin localization in the porcine epithelial cell line LLC-
PK1 was examined. As shown in Fig. 9, G and I, vinexin a
and b were detected at cellÐcell adhesions. For unknown
reasons, the fluorescence levels of diffuse vinexin a and b
were high, and vinexin a was often aggregated in LLC-
PK1 cells.
Vinexin aÐexpressing cells also showed unusually strong
rhodamine-phalloidin staining at focal adhesions, so that
the actin stress fibers had swollen ends in these cells. This
effect was particularly clearly observed by confocal mi-
croscopy, as shown in Fig. 10. The actin stress fibers in vi-
nexin aÐexpressing cells were often stained strongly with
rhodamine-phalloidin, though it was difficult to quanti-
tate. In vinexin bÐexpressing cells, modest increases in size
of focal adhesions were also observed (Fig. 10, GÐI). Simi-
lar results were obtained with FLAG-tagged vinexin a and
b (data not shown). In cells that expressed vinexin at high
levels, aggregations of GFP fluorescence or FLAG indi-
rect immunostaining were sometimes observed that lacked
colocalized actin (Fig. 10, D and F).
Since vinexin may have several structural domains, vari-
ous parts of vinexin were expressed separately (Fig. 8) and
examined for subcellular localization (Fig. 11). As ex-
pected, the GFP-fused insert of pVBP containing the two
SH3 domains required for vinculin binding localized to fo-
Figure 7. Deletion analysis of the vinculin proline-rich region.
Three cDNA fragments from the chicken vinculin proline-rich
region were cloned in pGBT9 (pGB410, pGB410d1, pGB410d2)
and assayed for interaction with the vinculin binding region of
vinexin using the yeast two-hybrid system. (A) Sequences of the
fragments are indicated by the black lines along the sequence of
vinculin (836Ð893). The VASP binding site (Brindle et al., 1996;
Reinhard et al., 1996) is also shown. Two putative SH3-binding
core sequences are also indicated with dots marking the con-
served proline residues (see Discussion). (B) The yeast strain
HF7c was transformed with each pair of plasmids and assayed for
b galactosidase activity, shown here in arbitrary units. pVBP con-
tains the 1-kb insert of vinexin initially isolated by the yeast two-
hybrid screening in pGAD424, which is the original plasmid with-
out an insert. The experiment was repeated three times, and
means and SD are shown.
Figure 8. Construction of expression plasmids. A schematic dia-
gram of vinexin a is presented at the top. The open reading frame
for vinexin a is shown by the open box. Three SH3 domains are
indicated by grey boxes numbered sequentially from the amino
terminus. The approximate position of each DNA fragment is
shown by a line with its name. The GFP coding sequence is fused
in frame to the 59 end of each clone.Kioka et al. Vinexin Enhances Actin Cytoskeletal Organization 65
cal adhesions. GFP-fused minimal vinculin binding do-
main (pGFP1st2ndSH3) showed similar localization (data
not shown). In contrast, the carboxyl-terminal SH3 do-
main (pGFP3rdSH3) showed a diffuse pattern of localiza-
tion. Interestingly, the amino-terminal half of vinexin a
(pGFPVxH) was also localized in focal adhesions in NIH
3T3 cells (Fig. 11), indicating the existence of focal ad-
hesionÐbinding activity in this domain. In contrast to vi-
nexin a, expression of the amino-terminal half of vinexin a
did not change actin cytoskeletal organization (data not
shown).
Expression of Vinexin Enhances Cell Spreading
Since vinexin appeared to be a novel protein of focal adhe-
sions, we examined the effect of vinexin expression on cell
spreading on a fibronectin substrate. Two stably express-
ing clones of C2C12 cells with vinexin b were isolated and
assayed for cell-spreading activity. As shown in Fig. 12,
vinexin  bÐexpressing cells showed enhanced cell spreading
on fibronectin substrates compared with mock transfec-
tants and untreated C2C12 cells. For unknown reasons, we
have not yet been able to isolate stable vinexin aÐexpress-
ing C2C12 cells, or vinexin aÐ and bÐexpressing NIH 3T3
cells. 
Discussion
We have identified and characterized a novel SH3 do-
main-containing protein termed vinexin. The vinculin-
binding sequence of vinexin was mapped within the region
extending from the first SH3 domain to the second using
the yeast two-hybrid system and an in vitro binding assay.
This mapping result was consistent with the results ob-
tained in the vinexin-expression experiments, in which vi-
nexin a and b and the vinculin-binding region were ex-
pressed in NIH 3T3 cells: all resulted in localizations at
focal adhesions. They also localized to cellÐcell adhesions
in epithelial LLC-PK1 cells. Expression of vinexin a also
promoted an increase in vinculin staining at focal adhe-
sions. These results were consistent with the notion that
Figure 9. Subcellular localization of vinexin. GFP-tagged vinexin a (A and B), b (C and D), and GFP (E and F) were each transfected
into NIH 3T3 cells. Vinexin-expressing and nonexpressing cells were examined for GFP fluorescence (A, C, and E) and indirect immu-
nofluorescence labeling for vinculin (B, D, and F). Note the presence of vinculin-free GFP fluorescent dots in NIH 3T3 cells highly
overexpressing GFP-vinexin a (A), suggesting aggregation of the fusion protein. GFP-tagged vinexin a (G and H), b (I and J), and GFP
(K and L) were also transfected into epithelial LLC-PK1 cells. Vinexin-expressing and nonexpressing cells were observed for GFP fluo-
rescence (G, I, and K) and indirect immunofluorescence labeling for b catenin (H, J, and L). Note that vinexin a is often aggregated in
the cytoplasm of LLC-PK1 cells. The scale bar indicates 20 mm.The Journal of Cell Biology, Volume 144, 1999 66
Figure 10. Confocal microscope images of cells expressing vinexin. Confocal images of an NIH 3T3 cell expressing GFP-tagged vinexin
a and nonexpressing cells, as observed by GFP fluorescence (A), rhodamine-phalloidin (B), and overlaid GFP and rhodamine fluores-
cence (C). The scale bar indicates 10 mm. Note that strong rhodamine-phalloidin staining was observed where GFP-tagged vinexin a
was localized. A different set of images (D, E, and F) is also shown for cells highly expressing vinexin a. In high expressers, aggregations
of GFP fluorescence were also observed (D and F, *). A vinexin bÐexpressing cell is shown by GFP fluorescence (G), rhodamine-phal-
loidin (H), and overlaid GFP and rhodamine fluorescence (I). Note the modestly strong rhodamine-phalloidin staining at focal adhe-
sions. As a control, a cell expressing GFP alone is shown (J, K, and L). This confocal microscope optical section was at the ventral sur-
face (bottom).Kioka et al. Vinexin Enhances Actin Cytoskeletal Organization 67
vinexin binds to vinculin in vivo. Thus, we propose that
vinexin is a novel vinculin-binding protein and also a novel
component in focal adhesion and cellÐcell adhesion.
We identified a novel binding sequence in the primary
structure of vinculin. This vinexin-binding sequence was
mapped within residues 849Ð893 of chicken vinculin. It is
now well established that SH3 domains bind to proline-
rich sequences of which the core sequence is ÒPXXP,Ó
where ÒPÓ is a proline residue and ÒXÓ for any amino acid
other than cysteine (Cohen et al., 1995). As shown in Fig. 7
A, it is possible to assign a pair of putative PXXP motifs in
the vinexin-binding region. Exact mapping of the vinexin-
binding site remains to be determined. It is also notewor-
thy that a high level of sequence conservation throughout
evolution of the vinexin-binding site of vinculin implies
the importance of the interaction between vinculin and
vinexin.
The specificity of interaction between single SH3 do-
main and the proline-rich motif has been studied exten-
sively. To our knowledge, this is the first demonstration
that a pair of SH3 domains is required for the specific in-
teraction of two proteins, although a similar multivalency-
dependent specificity has been proposed for the interac-
tion between Sos and Grb2 (Lim, 1996). In the case of the
SH2 domain, multivalency is known to raise the specificity
of SH2 domain interactions of ZAP-70 (Hatada et al.,
1995) and SH-PTP2 (Eck et al., 1996). This vinexinÐvincu-
lin interaction may provide a valuable insight into the
Figure 11. Subcellular localization of vinexin domains. GFP-
tagged vinexin domains were expressed in NIH 3T3 cells, and the
localization of each domain and vinculin were observed by GFP
fluorescence and indirect immunofluorescent staining for vincu-
lin. (A) GFP-tagged pVBP insert (pGFPVBP, see Fig. 8) was
transfected and GFP fluorescence was photographed. (B) The same
cells were also stained for vinculin localization. Cells transfected
with the GFPÐamino terminal domain of vinexin a (pGFPVxH)
were observed for GFP (C) and vinculin (D) localization. GFP-
tagged third SH3 domainÐtransfected cells (pGFP3rdSH3), ob-
served by GFP (E) and vinculin (F). Bar, 20 mm.
Figure 12. Effect of vinexin b expression on cell spreading. (A)
Two stable clones of C2C12 cells (#13 and #8) expressing vinexin
b were isolated. Two stable clones of mock-transfected cells (#2
and #4) using the expression vector (p401F) were included as
controls. FLAG-tagged vinexin b was detected by Western blot-
ting using antiÐFLAG antibody. (B) The cell-spreading activities
of these lines and mock transfectants were assayed by a cell-
spreading assay using fibronectin-coated substrates. The percent-
ages of cells that spread on fibronectin were determined and
shown as mean 6 SD.The Journal of Cell Biology, Volume 144, 1999 68
specificity of molecular recognition of multiple binding
modules.
The proline-rich region of vinculin has been examined
by several studies, and generally considered to be a hinge
between the head and tail domains (Jockusch et al., 1995).
There are two sites near the vinexin-binding region where
V8 protease readily cleaves vinculin (Price et al., 1989).
Thus, this region of vinculin is likely to be exposed on the
surface of the molecule. It has been shown that the cy-
toskeletal protein vasodilator-stimulated phosphoprotein
(VASP) binds to the adjacent proline-rich stretch (resi-
dues 842Ð846) of vinculin in vitro (Brindle et al., 1996;
Reinhard et al., 1996). The binding site of VASP is there-
fore very close to, but not overlapping with, the vinexin
binding sequence (Fig. 7 A). It will be interesting to deter-
mine whether VASP and vinexin can access the proline-
rich region of vinculin concurrently or exclusively of each
other.
Expression of vinexin a resulted in a significant increase
in the size of focal adhesions and also an increase in actin
stress fiber formation. Since the effects of vinexin b ex-
pression on actin cytoskeleton was not as conspicuous as
vinexin a, the amino-terminal half of vinexin a (referred
to hereafter as VxH domain) was suggeted to play roles in
the upregulation of actin cytoskeletal organization. Our
results also indicated that the VxH domain can bind to fo-
cal adhesions, since it became localized to cell adhesions
when the domain alone was expressed in NIH 3T3 cells.
Therefore, vinexin a contains multiple interaction sites to
focal adhesion components, as summarized in Fig. 13. The
ligand(s) of the third SH3 domain is unknown at present.
In contrast to the conspicuous effects on focal adhesions
and stress fibers of vinexin a, expression of the VxH do-
main alone resulted in no apparent effect on focal adhe-
sions and stress fibers. Thus, the VxH and the vinculin-
binding domains may act cooperatively to upregulate actin
cytoskeletal organization, although the exact molecular
mechanism remains to be examined.
Our results indicate that vinexin is a novel component of
focal adhesions with a capacity to interact with vinculin.
Numerous studies have been focused on the assembly of
integrin receptors, focal adhesion components, and actin
microfilaments. Focal adhesions are large macromolecular
assemblies, consisting of many proteins including vinculin,
talin, a-actinin, paxillin, and actin. The interaction and as-
sembly of the focal adhesion molecules are complex and
highly cooperative processes in which they are efficiently
recruited from diffusible pools within the cell and bound
to each other to form multimolecular complexes linked to
the actin cytoskeleton (Geiger et al., 1992; Jockusch et al.,
1995; Yamada and Geiger, 1997; Burridge et al., 1997). At
present, it is difficult to determine how vinexin a enhances
these processes. It is, however, noteworthy that the effect
of vinculin overexpression (Geiger et al., 1992) is similar
to that of vinexin a; i.e., a significant increase in the size of
focal adhesions and stress fibers. A possible cooperative
recruitment of vinculin and vinexin a to focal adhesions,
or stabilization of vinculin, may play an important role,
since our results showed that vinculin staining at focal ad-
hesions was markedly enhanced in vinexin aÐexpressing
cells.
We found that the effect of vinexin b expression on ac-
tin cytoskeletal organization was less than that of vinexin a.
Nevertheless, when stably transfected cells were assayed for
cell-spreading activities on fibronectin, vinexin bÐexpres-
sing clones showed significantly higher cell-spreading ac-
tivities than did mock-transfected cell lines. Since con-
formational alteration of vinculin has been suggested as
a mechanism for the modulation of vinculin function
(Johnson and Craig, 1994, 1995; Kroemker et al., 1994;
Schwienbacher et al., 1996), there is a possibility that vi-
nexin b may enhance cell spreading by modulating vincu-
lin conformation.
Homology searches of DNA and protein databases re-
vealed two other structurally related proteins, CAP and
ArgBP2. CAP, also known as SH3P12, was originally iso-
lated as a binding protein to proline-rich sequences in a
systematic screening experiment for SH3 domains (Sparks
et al., 1996), and later as a binding protein to c-Cbl (Ri-
bon et al., 1998b). ArgBP2 was isolated by a two-hybrid
screening for Arg- and Abl-binding proteins (Wang et al.,
1997). These two molecules and vinexin each contain three
SH3 domains, and CAP and ArgBP2 are most related to
each other at the sequence level. There are sequence ho-
mologies found in ArgBP2 and CAP with some stretches
of amino acid sequence within the vinexin VxH domain. In
contrast to vinexin, both CAP and ArgBP2 have been re-
ported to localize with actin stress fibers. Recently, expres-
sion of CAP was reported to enhance actin stress fiber for-
mation and focal adhesions, and association of CAP with
cytoskeletal signaling molecules such as p125 FAK was
Figure 13. Schematic diagram of multiple binding sites of vi-
nexin. A complex of vinexin and vinculin is depicted, with known
or potential ligands of each domain indicated. VxH represents
the amino-terminal half of vinexin a, suggested to bind to focal
adhesions. The three SH3 domains of vinexin are shown (1, 2,
and 3). The region extending from the first SH3 domain to the
second was mapped as the vinculin binding sequence, although a
portion of the VxH domain may also contribute to the interac-
tion between vinexin and vinculin, as suggested by in vitro bind-
ing assay (see Results). Note that the overall shape of vinexin as
depicted here is hypothetical, in contrast to the known shape of
vinculin based on electron microscopic images. The binding site
of VASP on vinculin is very close to the vinexin binding site.Kioka et al. Vinexin Enhances Actin Cytoskeletal Organization 69
suggested (Ribon et al., 1998a). These differences between
the two molecules and vinexin in subcellular localization
and association partners may indicate related but diverse
roles of these molecules. 
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